Dev Ittycheria - 01 Apr 2022 Form 4 Insider Report for MongoDB, Inc. (MDB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Apr 2022, 16:46:24 UTC
Prior SEC filing
15 Mar 2022
Next SEC filing
08 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Johnston, Attorney-in-Fact

Key filing fact

Dev Ittycheria filed Form 4 for MongoDB, Inc. (MDB) on 05 Apr 2022.

Key facts

  • This page summarizes Dev Ittycheria's Form 4 filing for MongoDB, Inc. (MDB).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Apr 2022, 16:46.

Change

  • Previous filing in this sequence was filed on 15 Mar 2022.
  • Current net transaction value: -$5,355,946.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDB transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+879
Change %
+0.41%
Price
$0.000000
Shares after
216,813
Date
01 Apr 2022
Ownership
Direct
Footnotes
F1
MDB transaction

Class A Common Stock

Sale

Transaction value
$5,331,897
Shares
-12,015
Change %
-5.5%
Price
$443.77
Shares after
204,798
Date
04 Apr 2022
Ownership
Direct
Footnotes
F2, F3
MDB transaction

Class A Common Stock

Sale

Transaction value
$20,479
Shares
-46
Change %
-0.02%
Price
$445.19
Shares after
204,752
Date
04 Apr 2022
Ownership
Direct
Footnotes
F2, F4
MDB transaction

Class A Common Stock

Sale

Transaction value
$3,571
Shares
-8
Change %
-0%
Price
$446.34
Shares after
204,744
Date
04 Apr 2022
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares of Class A common stock received upon the vesting of a portion of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on April 7, 2021 under the Issuer's annual bonus plan and 2016 Equity Incentive Plan, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16. Each RSU represents the contingent right to receive one share of common stock of the Issuer.

Footnote F2

Represents the sale of shares of Class A common stock to satisfy the Reporting Person's tax withholding obligations in connection with (i) the non-reportable service-based vesting and settlement of restricted stock units and (ii) the performance-based vesting and settlement of the above-listed RSUs.

Footnote F3

The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $442.79 to $443.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F4

The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $444.92 to $445.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .